BioEclipse Therapeutics, Inc

📍 Mountain View, United States🗓 Founded 2017👥 7 employees💰 Last funded Jun 2019
Biotechnology Research🌐 bioeclipse.com
Website LinkedIn
BioEclipse Therapeutics™ is a clinical-stage oncology company developing a new generation of precise, targeted, immunotherapies that bring hope to patients with advanced cancer who have few treatment options due to the challenges of resistant and recurrent cancers. Solid tumors have been a challenging obstacle for all cancer therapies, including immunotherapies, reporting high failuure rates. For six decades researchers have taken steps towards a cure, with remarkable progress in liquid tumors, but few inroads into solid tumors representing 90% of all cancers. Our technology represents a transformative approach that captures the true power of both innate and adaptive immunity to effectively treat even refractory solid tumors.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2016–2019 · investors recorded per year
2016220191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in BioEclipse Therapeutics, Inc?
BioEclipse Therapeutics, Inc has 3 investors on record on gritt.io, including 3 early-stage backers.
When did BioEclipse Therapeutics, Inc last raise funding?
The most recent investment in BioEclipse Therapeutics, Inc recorded on gritt.io was in June 2019.
When was BioEclipse Therapeutics, Inc founded?
BioEclipse Therapeutics, Inc was founded in 2017.
What industry is BioEclipse Therapeutics, Inc in?
BioEclipse Therapeutics, Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BioEclipse Therapeutics, Inc based?
BioEclipse Therapeutics, Inc is headquartered in Mountain View, United States.